August 14, 2009, 8:20 pm
Former Congressional Leader Departs Lobbying Firm
By David D. Kirkpatrick
WASHINGTON — Dick Armey, the former House Republican leader, has quit his job with the lobbying firm DLA Piper amid complaints from the firm’s drug company clients about his work opposing President Obama’s health care overhaul.
His departure is the latest example of the confusing entanglements arising from the health care debate.
To review the odd facts of this case: the drug companies who helped defeat the Clinton administration’s health care effort 15 years ago have turned on Mr. Armey, who then was one of their most important Congressional allies. Now, having cut a deal with the administration to limit their share of the costs, the drug companies are on the other side. Foreseeing new profits from the expansion of health coverage, they are spending as much as $150 million on advertisements to support it.
To their embarrassment, however, Mr. Armey has continued to oppose the idea as the chairman of the independent conservative group FreedomWorks. The group has helped turn out rowdy demonstrators at at town hall-style meetings with lawmakers around the country. And some liberal Web sites have begun connecting Mr. Armey’s fight against the health care legislation to his other work for DLA Piper’s drug company clients.
One of DLA Piper’s biggest clients is Medicines Company, which paid DLA Piper $240,000 in lobbying fees in the second quarter. Another drug maker, Sanofi Pasteur, paid the firm $30,000 during the same period, according to its latest disclosure forms.
FreedomWorks did not respond to requests for comment.
Frank Burch, chairman of DLA Piper, said in a press release that firm appreciated Mr. Armey “taking the initiative to clear up confusion concerning FreedomWorks.”
“Despite some unfounded media suggestions attempting to link DLA Piper to FreedomWorks’s opposition to health care reform, the firm has not, on its own behalf, or on the behalf of any client, directly or indirectly opposed any of the pending health care reform bills,” Mr. Burch said. “On the contrary, DLA Piper represents clients who support enactment of effective health care reform this year.”